Form 4: VolitionRx Secretary's Tax Withholding on RSU Vesting
Insider Transaction Report
VolitionRx's Secretary, Rodney Gerard Rootsaert, reported a disposition of 4,620 common shares to cover tax obligations related to the vesting of 11,000 restricted stock units.
Summary
- Rodney Gerard Rootsaert, Secretary and Director of VolitionRx Ltd., reported a transaction on October 4, 2025.
- The transaction involved the disposition of 4,620 shares of VolitionRx common stock at a price of $0.648 per share.
- These shares were retained by VolitionRx for cancellation to satisfy tax withholding obligations arising from the settlement of 11,000 restricted stock units (RSUs).
- No shares were sold by the reporting person or VolitionRx in this transaction.
- Following this transaction, Rodney Gerard Rootsaert directly beneficially owns 140,455 shares of common stock.
- He also indirectly beneficially owns 1,007,718 shares through Concord International, Inc., where he is a controlling director and shares voting and dispositive control.
- The transaction was made pursuant to a Rule 10b5-1(c) plan.
Sentiment
Score: 6
Explanation: The filing reports a routine tax withholding transaction related to RSU vesting for a key officer, indicating ongoing compensation and retention, which is generally neutral to slightly positive for corporate governance and executive alignment.
Positives
- Vesting of 11,000 restricted stock units indicates continued compensation and retention of a key officer.
Negatives
- A minor reduction in direct beneficial ownership due to tax withholding, which is a routine event.
Future Outlook
NA
Industry Context
This is a routine insider transaction related to executive compensation and does not provide specific insights into broader industry trends or competitive landscape.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Insider Trading Policy | The transaction was executed under a Rule 10b5-1(c) plan, indicating a pre-arranged trading strategy designed to comply with insider trading regulations. | 10/04/2025 | Enhances transparency and reduces potential for insider trading concerns by establishing a pre-planned schedule for stock transactions. |
Related Party Transactions
- Indirect beneficial ownership of 1,007,718 shares through Concord International, Inc., where the reporting person is a controlling director and shares voting and dispositive control.
Stakeholder Impact
- Shareholders: Provides transparency regarding executive compensation and beneficial ownership, with minimal direct impact on company operations or valuation from this routine transaction.
- Employees: Reflects standard executive compensation practices, potentially signaling stability in management retention.
Key Dates
| Date | Description |
|---|---|
| 10/04/2025 | Date of earliest transaction, representing the settlement of restricted stock units and associated tax withholding. |
| 10/07/2025 | Signature date of the reporting person on the Form 4 filing. |
Recommendation
holdThis Form 4 details a routine tax withholding event for an executive's restricted stock unit vesting, not a discretionary sale. Such transactions are common and typically do not reflect a change in the company's operational performance or the insider's long-term view, thus not warranting a change in investment recommendation based solely on this filing.
Keywords
VolitionRx, VNRX, Form 4, Insider Transaction, Rodney Gerard Rootsaert, Restricted Stock Units, Tax Withholding, Beneficial Ownership, Corporate Governance
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.